Production (Stage)
Compass Therapeutics, Inc.
CMPX
$2.37
-$0.04-1.66%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -21.51% | -16.19% | -17.42% | -10.68% | -13.89% |
| Total Depreciation and Amortization | -11.65% | -7.25% | -2.31% | -3.32% | -4.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 103.33% | 138.74% | 127.34% | 74.21% | 8.09% |
| Change in Net Operating Assets | 161.52% | -42.43% | -196.50% | 62.53% | 36.53% |
| Cash from Operations | -4.49% | -10.43% | -23.50% | 2.29% | -10.06% |
| Capital Expenditure | -106.67% | -46.67% | 29.33% | 79.35% | -66.67% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 235.65% | 73.42% | 245.71% | 161.68% | 112.68% |
| Cash from Investing | 235.86% | 73.45% | 245.09% | 161.50% | 112.67% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | 468.16% | -77.20% | -77.17% | -72.13% |
| Repurchase of Common Stock | -208.81% | -45.91% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.16% | -477.66% | 7.80% | 8.14% | -28.89% |
| Cash from Financing | -104.48% | 490.73% | -78.09% | -78.06% | -73.18% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 618.16% | 279.65% | -50.21% | 101.81% | 96.93% |